Clinilabs Drug Development Corporation provides access to the world’s largest population of racially diverse clinical trial participants. We recruit healthy volunteers, patients, and specialty groups from a population of more than 19 million people in the New York metropolitan area. Our on-site call center employs highly-experienced, multilingual associates who pre-screen study candidates using the latest technology in order to ensure that our proprietary database is the most robust in the industry. We currently have more than 43,000 study candidates in our database. Click here to determine if our database includes the subject population that you are seeking.
Clinilabs promotes gender and racial diversity in clinical trials, which we conduct to develop new therapies for the CNS disorders listed below.
Normal Healthy Subjects
Post-tramatic stress disorders
Tramatic brain injury
Circadian rhythm disorders
Endocrine and Metabolic Disorders
Men’s and Women’s Health
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
– George W. Merck